4/A//SEC Filing
SCHWARTZ MARK W. 4/A
Accession 0001250853-13-000026
CIK 0001390478other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:36 PM ET
Size
5.5 KB
Accession
0001250853-13-000026
Insider Transaction Report
Form 4/AAmended
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Award
Common Stock
2011-04-13+330,872→ 330,872 total
Footnotes (1)
- [F1]The shares shown were received by Reporting Person in exchange for 2,776,796 shares of Apthera, Inc. ("Apthera") common stock in connection with the Issuer's merger acquisition of Apthera, with Apthera surviving as a wholly-owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $1.275 per share. The shares shown exclude 6,789 shares, which were included in error in the Reporting Person's original Form 4.
Documents
Issuer
Galena Biopharma, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001422882
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 6:36 PM ET
- Size
- 5.5 KB